Virtus LifeSci Biotech Clinical Trials ETF
18 hedge funds and large institutions have $7.19M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 3 closing their positions.
Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
GRP
1
Global Retirement Partners
San Rafael,
California
|
$8K |
2 |
MCC
2
Money Concepts Capital
Palm Beach Gardens,
Florida
|
$6K |
3 |
ARMC
3
American Research & Management Company
Marion,
Massachusetts
|
$3K |